ESMO Preceptorship on Immuno-Oncology 2023 Zurich

Regular price
$20.00
Sale price
$20.00
Regular price
$0
Sold out
Unit price
Quantity must be 1 or more

European Society for Medical Oncology Preceptorship on Immuno-Oncology 2023 Zurich

Format: 19 videos + 21 pdfs, size: 2.04 GB

Course Audience: oncologist, immunologist

Overview:

Start date: 29 Sep 2023

End date: 30 Sep 2023

Location: Zurich, Switzerland

Learning objectives

  • To understand the basics of tumour immunology
  • To learn about the essentials of immunotherapies and their applications in cancer medicine
  • To learn about the status of development and clinical experience of immunotherapy in different tumour type

ESMO-Preceptorship-on-Immuno-Oncology-2023-Zurich-Programme (PDF Format)

Session 1 Adjuvant vs neoadjuvant (Video MP4 Format)

Session 1 Adjuvant vs neoadjuvant (PDF Format)

Session 1 Basic tumour immunology for oncologists (Video MP4 Format)

Session 1 Basic tumour immunology for oncologists (PDF Format)

Session 1 Biomarkers for immunotherapy (Video MP4 Format)

Session 1 Biomarkers for immunotherapy (PDF Format)

Session 1 Mechanisms of immune resistance (Video MP4 Format)

Session 1 Mechanisms of immune resistance (PDF Format)

Session 2 Immunotherapy for NSCLC (Video MP4 Format)

Session 2 Immunotherapy for NSCLC (PDF Format)

Session 2 Immunotherapy for SCLC and Mesothelioma (Video MP4 Format)

Session 2 Immunotherapy for SCLC and Mesothelioma (PDF Format)

Session 3 Immunotherapy for breast cancer (Video MP4 Format)

Session 3 Immunotherapy for breast cancer (PDF Format)

Session 3 Immunotherapy for gynaecological malignancies (Video MP4 Format)

Session 3 Immunotherapy for gynaecological malignancies (PDF Format)

Session 4 Immunotherapy for gastro-intestinal cancers (Video MP4 Format)

Session 4 Immunotherapy for gastro-intestinal cancers (PDF Format)

Session 5 Developments in adoptive T-cell transfer (Video MP4 Format)

Session 5 Developments in adoptive T-cell transfer (PDF Format)

Session 5 Developments in immune checkpoint inhibition (Video MP4 Format)

Session 5 Developments in immune checkpoint inhibition (PDF Format)

Session 6 Immunotherapy for liver and biliary cancer (Video MP4 Format)

Session 6 Immunotherapy for liver and biliary cancer (PDF Format)

Session 8 IrAEs and management of toxicities (Video MP4 Format)

Session 8 IrAEs and management of toxicities (PDF Format)

Session 9 Participant Clinical Case Discussion Autoimmune Flares – A Big Headache (Video MP4 Format)

Session 9 Participant Clinical Case Discussion Autoimmune Flares – A Big Headache (PDF Format)

Session 9 Participant Clinical Case Discussion Challenges with Immunotherapy in Hepatocellular Carcinoma and Lung Cancer (Video MP4 Format)

Session 9 Participant Clinical Case Discussion Challenges with Immunotherapy in Hepatocellular Carcinoma and Lung Cancer (PDF Format)

Session 9 Participant Clinical Case Discussion First-line Immune Checkpoint Blockade after adjuvant immunotherapy failure? to do or not to do (Video MP4 Format)

Session 9 Participant Clinical Case Discussion First-line Immune Checkpoint Blockade after adjuvant immunotherapy failure? to do or not to do (PDF Format)

Session 9 Participant Clinical Case Discussion Immediate and late toxicities from Nivolumab (Video MP4 Format)

Session 9 Participant Clinical Case Discussion Immediate and late toxicities from Nivolumab (PDF Format)

Session 9 Participant Clinical Case Discussion Immune-related limbic encephalitis in a patient with unresectable locally advanced sqNSCLC (Video MP4 Format)

Session 9 Participant Clinical Case Discussion Immune-related limbic encephalitis in a patient with unresectable locally advanced sqNSCLC (PDF Format)

Session 9 Participant Clinical Case Discussion My, oh My, oh My A Case of Myocarditis, Myositis, Myasthenia Overlap Syndrome (Video MP4 Format)

Session 9 Participant Clinical Case Discussion My, oh My, oh My A Case of Myocarditis, Myositis, Myasthenia Overlap Syndrome (PDF Format)

Welcome and Introduction (PDF Format)

Go to full site